Skip to main content
Fig. 5 | BMC Veterinary Research

Fig. 5

From: Anti-cancer effects of DHP107 on canine mammary gland cancer examined through in-vitro and in-vivo mouse xenograft models

Fig. 5

Toxicity of oral paclitaxel in the xenograft model. (A) The body weights of mice were monitored twice a week during paclitaxel treatment. Data are expressed as mean ± standard deviation. (B) After 21 days of treatment, mice were sacrificed. Gastrointestinal tissues were sampled to evaluate gastrointestinal adverse events of oral paclitaxel

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us